TY - JOUR T1 - Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 1563 LP - 1564 DO - 10.1136/bjo.2007.115626 VL - 91 IS - 11 AU - Carsten Heinz AU - Hartmut Merz AU - Matthias Nieschalk AU - Heribert Mueller-Miny AU - Peter Koch AU - Arnd Heiligenhaus Y1 - 2007/11/01 UR - http://bjo.bmj.com/content/91/11/1563.abstract N2 - Extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) of the lacrimal gland is a rare condition. Treatment options chiefly include radiation of the tumour, chemotherapy, surgical removal or a combination of these strategies.1 Radiation therapy is associated with a high risk of ocular morbidity, especially dry eye.1 Here, we report a case of a biopsy-proven extranodal MALT lymphoma of the lacrimal gland treated with two courses of four weekly cycles of rituximab.A 64-year-old woman presented with unilateral ptosis and swelling of her right lacrimal gland. Best-corrected visual acuity was 20/25. Slit-lamp examination showed severe punctate superficial keratopathy (basal secretion 0 mm OU). … ER -